Literature DB >> 26086181

Incidence of dementia and subtypes: A cohort study in four regions in China.

Jing Yuan1, Zhenxin Zhang2, Hongbo Wen1, Xia Hong1, Zhen Hong3, Qiumin Qu4, Mouni Tang5, Jixing Wu6, Qun Xu7, Hui Li7, Jeffrey L Cummings8.   

Abstract

INTRODUCTION: There is a dearth of literature on the incidence of dementia in China.
METHODS: Using a stratified, multistage, cluster-sampling method, 16,921 nondemented participants ≥55 years were recruited from four regional centers in China in 1997 and followed up to 4.5 years. Cases were identified through a three-step protocol, according to standardized criteria for dementia, Alzheimer's dementia (AD), and vascular dementia (VaD).
RESULTS: The crude incidence in persons ≥65 years was 12.1/1000 person-years for dementia, 8.2/1000 person-years for AD, and 3.1/1000 person-years for VaD. After adjusting for sociodemographic factors, older age and lower education were associated with a higher risk of incident dementia, AD and VaD; regional difference was associated mainly with incidence of VaD (north vs. south: hazard ratio [HR] = 3.59); modestly with AD (east vs. west: HR = 1.55). DISCUSSION: The incidence of dementia in Chinese population is comparable with that in Europe and United States.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; China; Dementia; Epidemiology; Incidence; Prospective cohort study; Risk factors; Vascular dementia

Mesh:

Year:  2015        PMID: 26086181     DOI: 10.1016/j.jalz.2015.02.011

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  18 in total

1.  Validation of neuropsychological tests for the China Health and Retirement Longitudinal Study Harmonized Cognitive Assessment Protocol.

Authors:  Qinqin Meng; Huali Wang; John Strauss; Kenneth M Langa; Xinxin Chen; Mingwei Wang; Qiumin Qu; Wei Chen; Weihong Kuang; Nan Zhang; Tao Li; Yafeng Wang; Yaohui Zhao
Journal:  Int Psychogeriatr       Date:  2019-07-16       Impact factor: 3.878

2.  Risk factors for in-hospital death in elderly patients over 65 years of age with dementia: A retrospective cross-sectional study.

Authors:  Zhangmin Meng; Linan Cheng; Xiuying Hu; Qian Chen
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

3.  Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.

Authors:  Yawen Sun; Xin Ge; Xu Han; Wenwei Cao; Yao Wang; Weina Ding; Mengqiu Cao; Yong Zhang; Qun Xu; Yan Zhou; Jianrong Xu
Journal:  Front Aging Neurosci       Date:  2017-03-30       Impact factor: 5.750

4.  The Discrepancy of Neurological Diseases between China and Western Countries in Recent Two Decades.

Authors:  Jun Ni; Fei Han; Jing Yuan; Han Wang; Dong-Chao Shen; Yan Xu; Li-Ying Cui
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

5.  Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP/PS1 mice.

Authors:  Jun Wang; Bin-Lu Sun; Yang Xiang; Ding-Yuan Tian; Chi Zhu; Wei-Wei Li; Yu-Hui Liu; Xian-Le Bu; Lin-Lin Shen; Wang-Sheng Jin; Zhen Wang; Gui-Hua Zeng; Wei Xu; Li-Yong Chen; Xiao-Wei Chen; Zhian Hu; Zhi-Ming Zhu; Weihong Song; Hua-Dong Zhou; Jin-Tai Yu; Yan-Jiang Wang
Journal:  Transl Psychiatry       Date:  2020-07-13       Impact factor: 6.222

6.  China's shift from population control to population quality: Implications for neurology.

Authors:  Qing Ke; Li Zhang; Chaying He; Zhengyan Zhao; Ming Qi; Robert C Griggs; Michele A Gatheridge
Journal:  Neurology       Date:  2016-08-23       Impact factor: 9.910

7.  Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia.

Authors:  Peng Wu; Yuandai Luo; Lifang Zhen; Xianda Hu; Ying Shang; Yinuo Liao; Huiyuan Xue; Fukai Huang; Wei Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-17       Impact factor: 2.629

Review 8.  Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients.

Authors:  Nan Zhang; Marc L Gordon
Journal:  Clin Interv Aging       Date:  2018-10-11       Impact factor: 4.458

Review 9.  The continuum of care for dementia: needs, resources and practice in China.

Authors:  Huali Wang; Hengge Xie; Qiumin Qu; Wei Chen; Yongan Sun; Nan Zhang; Yu Liu; Tao Li; Kit Yee Chan; Serge Gauthier; Xin Yu
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

Review 10.  Physical activity and cognitive function among older adults in China: A systematic review.

Authors:  Jiaojiao Lü; Weijie Fu; Yu Liu
Journal:  J Sport Health Sci       Date:  2016-07-11       Impact factor: 7.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.